SynthesisAnnals of hematology2022

Adverse events in lymphoma patients treated with phosphoinositide 3 kinase Inhibitor in clinical trials: a meta-analysis.

Weihang Shan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.